Diversity and Function of Mutations in P450 Oxidoreductase in Patients with Antley-Bixler Syndrome and Disordered Steroidogenesis
Open accessThe DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Abstract
P450 oxidoreductase (POR) is the obligatory flavoprotein intermediate that transfers electrons from reduced nicotinamide adenine dinucleotide phosphate (NADPH) to all microsomal cytochrome P450 enzymes. Although mouse Por gene ablation causes embryonic lethality, POR missense mutations cause disordered steroidogenesis, ambiguous genitalia, and Antley-Bixler syndrome (ABS), which has also been attributed to fibroblast growth factor receptor 2 (FGFR2) mutations. We sequenced the POR gene and FGFR2 exons 8 and 10 in 32 individuals with ABS and/or hormonal findings that suggested POR deficiency. POR and FGFR2 mutations segregated completely. Fifteen patients carried POR mutations on both alleles, 4 carried mutations on only one allele, 10 carried FGFR2 or FGFR3 mutations, and 3 patients carried no mutations. The 34 affected POR alleles included 10 with A287P (all from whites) and 7 with R457H (four Japanese, one African, two whites); 17 of the 34 alleles carried 16 "private" mutations, including 9 missense and 7 frameshift mutations. These 11 missense mutations, plus 10 others found in databases or reported elsewhere, were recreated by site-directed mutagenesis and were assessed by four assays: reduction of cytochrome c, oxidation of NADPH, support of 17alpha-hydroxylase activity, and support of 17,20 lyase using human P450c17. Assays that were based on cytochrome c, which is not a physiologic substrate for POR, correlated poorly with clinical phenotype, but assays that were base…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas most genetically determined craniosynostosis is characterised by dominant inheritance, Antley-Bixler syndrome (features include disordered sex development and radio-humeral synostosis; mutation in POR encoding cytochrome P450 oxidoreductase) 35 and Carpenter syndrome (with polysyndactyly; mutation in RAB23 encoding RAB23, member of RAS oncogene family) 36 are recessive disorders.”
From Craniosynostosis (2011) · cites this paper as [35]
In the citing paper
“These mutations demonstrate pathogenic roles for steroid metabolism and hedgehog (or possibly Wnt) signalling in cranial suture development, both of which are at present poorly understood.”
From Craniosynostosis (2011) · cites this paper as [35]
In the citing paper
“POR is located in the endoplasmic reticulum of the cells, where it operates as an electron donor for the cytochromes P450, heme oxygenase, squalene monooxygenase, and other redox partners [2,3,4].”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [4]
In the citing paper
“Considering all available data from previous reports [4,46,47] and multiple functional assays described in this manuscript, we suggest that rs17853284, the variant causing amino acid change P228L in POR, is a disease-causing variant, whose effect will be prominent when present together with another variant of POR on the second allele that has a severe impact on POR activities.”
From Loss of Protein Stability and Function Caused by P228L Variation in NADPH-Cytochrome P450 Reductase Linked to Lower Testosterone Levels (2022) · cites this paper as [4]
In the citing paper
“Before our study only two p.A287P homozygous patients have been described; one with an unclear karyotype and genital appearance (7) and the other with ambiguous genitalia and 46,XY DSD (3).”
From Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency (2012) · cites this paper as [7]
27 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Thompson, J. D., Higgins, D. G., & Gibson, T. J. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.22.4673 · Cited by 64,617 · cited 2×
“The POR sequences from human, rat, Xenopus, Drosophila, and yeast were aligned with ClustalW (Thompson et al. 1994), and sequences were displayed and ed-”
MethodComparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
The Carbon Monoxide-binding Pigment of Liver Microsomes
Omura, T., & Sato, R. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)82244-3 · Cited by 11,781
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
Guex, N., & Peitsch, M. C. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150181505 · Cited by 11,241
Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Modeling of loops in protein structures
Fiser, A., Do, R. K. G., & Šali, A. (2000) · Protein Science · doi:10.1110/ps.9.9.1753 · Cited by 2,116 · cited 1×
“Molecular modeling of human POR was performed by MODELLER (Sali and Blundell 1993; Fiser et al. 2000), which uses satisfaction of spatial restraints for comparative modeling of proteins.”
MethodMiroux, B., & Walker, J. E. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0399 · Cited by 1,959
Congenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Apert syndrome results from localized mutations of FGFR2 and is allelic with Crouzon syndrome
Wilkie, A. O. M., Slaney, S. F., Oldridge, M., Poole, M. D., Ashworth, G. J., Hockley, A. D., Hayward, R. D., David, D. J., Pulleyn, L. J., Rutland, P., et al. (1995) · Nature Genetics · doi:10.1038/ng0295-165 · Cited by 935
Self-citation
Cited by
Items 101–200 of 336
Chen, X., Pan, L. Q., Naranmandura, H., Zeng, S., & Chen, S. Q. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038495 · Cited by 53
Fernández‐Cancio, M., Camats, N., Flück, C. E., Zalewski, A., Dick, B., Frey, B. M., Monné, R., Torán, N., Audí, L., & Pandey, A. V. (2018) · Pharmaceuticals · doi:10.3390/ph11020037 · Cited by 49
Self-citationDean, B., Chrisp, G. L., Quartararo, M., Maguire, A. M., Hameed, S., King, B. R., Munns, C. F., Torpy, D. J., Falhammar, H., & Rushworth, R. L. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz255 · Cited by 43
Bozcaarmutlu, A., & Arınç, E. (2006) · Toxicology in Vitro · doi:10.1016/j.tiv.2006.10.002 · Cited by 44
Subramanian, M., Agrawal, V., Sandee, D., Tam, H. K., Miller, W. L., & Tracy, T. S. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3283544062 · Cited by 43
Self-citationStewart, P. M., & Krone, N. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0324-5.00015-8 · Cited by 61
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Self-citationElens, L., Nieuweboer, A. J. M., Clarke, S. J., Charles, K. A., de Graan, A. M., Haufroid, V., van Gelder, T., Mathijssen, R. H. J., & van Schaik, R. H. N. (2013) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835dc113 · Cited by 46
Udhane, S. S., Parween, S., Kagawa, N., & Pandey, A. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00580 · Cited by 38
Self-citationYang, G., Fu, Z.-M., Chen, X., Yuan, H., Yang, H., Huang, Y., Ouyang, D., Tan, Z.-R., Tan, H., Huang, Z., et al. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.11.004 · Cited by 45
Spectrum of Antley-Bixler Syndrome
McGlaughlin, K. L., Witherow, H., Dunaway, D. J., David, D. J., & Anderson, P. J. (2010) · Journal of Craniofacial Surgery · doi:10.1097/scs.0b013e3181ec6afe · Cited by 41
Diagnosis and Treatment of Disorders of Sexual Development
Rey, R. A., & Josso, N. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00119-0 · Cited by 40
Flück, C. E., Mallet, D., Hofer, G., Samara‐Boustani, D., Léger, J., Polak, M., Morel, Y., & Pandey, A. V. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.001 · Cited by 43
Self-citationImpact on CYP19A1 activity by mutations in NADPH cytochrome P450 oxidoreductase
Flück, C. E., & Pandey, A. V. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.031 · Cited by 43
Self-citationParween, S., DiNardo, G., Baj, F., Zhang, C., Gilardi, G., & Pandey, A. V. (2020) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105507 · Cited by 39
Self-citationGea, M., Zhang, C., Tota, R., Gilardi, G., Nardo, G. D., & Schilirò, T. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19041959 · Cited by 43
Parween, S., Roucher-Boulez, F., Flück, C. E., Lienhardt-Roussie, A., Mallet, D., Morel, Y., & Pandey, A. V. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1928 · Cited by 37
Self-citationAdrenal androgens, adrenarche, and zona reticularis: A human affair?
Dumontet, T., & Martinez, A. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111239 · Cited by 44
Pandey, A. V., Flück, C. E., & Mullis, P. E. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.08.072 · Cited by 36
Self-citationUpdate on Adrenarche—Still a Mystery
Augsburger, P., Liimatta, J., & Flück, C. E. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae008 · Cited by 48
Self-citationYim, S.-K., Jung, H.-C., Pan, J., Kang, H., Ahn, T., & Yun, C. (2006) · Protein Expression and Purification · doi:10.1016/j.pep.2006.05.013 · Cited by 37
Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide Bioactivation
Serafi, I. E., Afsharian, P., Moshfegh, A., Hassan, M., & Terelius, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141979 · Cited by 39
Translating genomics to the clinical diagnosis of disorders/differences of sex development
Parivesh, A., Barseghyan, H., Délot, E. C., & Vilain, E. J. N. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2019.01.005 · Cited by 39
The classic and nonclassic concenital adrenal hyperplasias
Auchus, R. J. (2015) · Endocrine Practice · doi:10.4158/ep14474.ra · Cited by 35
Li, H., Zhao, A., Xie, M., Chen, L., Wu, H., Shen, Y., & Wang, H. (2021) · Translational Pediatrics · doi:10.21037/tp-21-499 · Cited by 36
Kranc, W., Brązert, M., Ożegowska, K., Nawrocki, M. J., Budna, J., Celichowski, P., Dyszkiewicz-Konwińska, M., Jankowski, M., Ješeta, M., Pawelczyk, L. A., et al. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122673 · Cited by 37
Witchel, S. F., & Topaloglu, A. K. (2019) · Yen and Jaffe's Reproductive Endocrinology · doi:10.1016/b978-0-323-47912-7.00017-2 · Cited by 35
Bai, Y., Li, J., & Wang, X. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0312-9 · Cited by 34
POR R457H is a global founder mutation causing Antley–Bixler syndrome with autosomal recessive trait
Adachi, M., Asakura, Y., Matsuo, M., Yamamoto, T., Hanaki, K., & Arlt, W. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31112 · Cited by 34
McCammon, K. M., Panda, S. P., Xia, C., Kim, J.-J. P., Moutinho, D., Kranendonk, M., Auchus, R. J., Lafer, E. M., Ghosh, D., Martasek, P., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.716019 · Cited by 33
Cytochrome P450 Oxidoreductase Deficiency
Idkowiak, J., Cragun, D. L., Hopkin, R. J., & Arlt, W. (2009) · University of Washington, Seattle eBooks · Cited by 33
ATR3 encodes a diflavin reductase essential for Arabidopsis embryo development
Varadarajan, J., Guilleminot, J., Saint‐Jore‐Dupas, C., Piégu, B., Chabouté, M., Gomord, V., Coolbaugh, R. C., Devic, M., & Delorme‐Hinoux, V. (2010) · New Phytologist · doi:10.1111/j.1469-8137.2010.03254.x · Cited by 38
Janner, M., Pandey, A. V., Mullis, P. E., & Flück, C. E. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02172 · Cited by 33
Self-citationHlavica, P. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-16009-2_10 · Cited by 32
Electron Transfer Pathways in Cholesterol Synthesis
Porter, T. D. (2015) · Lipids · doi:10.1007/s11745-015-4065-1 · Cited by 34
Dobrinas, M., Cornuz, J., Pedrido, L., & Eap, C. B. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834e9e1a · Cited by 32
Polymorphisms in cytochrome P450 oxidoreductase and its effect on drug metabolism and efficacy
Gong, L., Zhang, C., Lv, J., Zhou, H., & Fan, L. (2017) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000297 · Cited by 35
Papadakis, G. E., Dumont, A., Bouligand, J., Chasseloup, F., Raggi, A., Catteau-Jonard, S., Boute‐Bénéjean, O., Pitteloud, N., Young, J., & Dewailly, D. (2020) · Human Reproduction · doi:10.1093/humrep/deaa020 · Cited by 38
Nomenclature for alleles of the cytochrome P450 oxidoreductase gene
Sim, S. C., Miller, W. L., Zhong, X.-B., Arlt, W., Ogata, T., Ding, X., Roland Wolf, C., Flück, C. E., Pandey, A. V., Henderson, C. J., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32832af5b7 · Cited by 31
Self-citationWang, Y.-H., Tee, M. K., & Miller, W. L. (2010) · Endocrinology · doi:10.1210/en.2009-1247 · Cited by 31
Self-citationMoutinho, D., Marohnic, C. C., Panda, S. P., Rueff, J., Masters, B. S. S., & Kranendonk, M. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.042820 · Cited by 38
Cytochromes P450—A Family of Proteins and Scientists–Understanding their Relationships
Masters, B. S. S., & Marohnic, C. C. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600570065 · Cited by 35
P450 oxidoreductase deficiency and Antley–Bixler syndrome
Arlt, W. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9056-y · Cited by 36
The human adrenal cortex: growth control and disorders
Lotfi, C. F. P., Kremer, J. L., Passaia, B. D. S., & Cavalcante, I. P. (2018) · Clinics · doi:10.6061/clinics/2018/e473s · Cited by 36
Fukami, M., Nagai, T., Mochizuki, H., Muroya, K., Yamada, G., Takitani, K., & Ogata, T. (2010) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2010.03.023 · Cited by 30
Koyama, Y., Homma, K., Fukami, M., Miwa, M., Ikeda, K., Ogata, T., Hasegawa, T., & Murata, M. (2012) · Clinical Chemistry · doi:10.1373/clinchem.2011.173286 · Cited by 30
P450 Oxidoreductase Deficiency: A New Disorder of Steroidogenesis
Miller, W. L., Huang, N., Pandey, A. V., Flück, C. E., & Agrawal, V. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1336.012 · Cited by 37
Self-citationModeling of human P450 oxidoreductase structure by in silico mutagenesis and MD simulation
Flück, C. E., Mullis, P. E., & Pandey, A. V. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.09.001 · Cited by 31
Self-citationWilliamson, L., Arlt, W., Shackleton, C., Kelley, R. I., & Braddock, S. R. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31385 · Cited by 30
History of Adrenal Research: From Ancient Anatomy to Contemporary Molecular Biology
Miller, W. L., & White, P. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac019 · Cited by 35
Self-citationClinical and molecular review of atypical congenital adrenal hyperplasia
Sahakitrungruang, T. (2015) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2015.20.1.1 · Cited by 30
High-Yield Expression of a Catalytically Active Membrane-Bound Protein: Human P450 Oxidoreductase
Sandee, D., & Miller, W. L. (2011) · Endocrinology · doi:10.1210/en.2011-0230 · Cited by 29
Self-citationMiller, W. L. (2012) · Science Signaling · doi:10.1126/scisignal.2003318 · Cited by 34
Self-citationLi, Z., Chadalapaka, G., Ramesh, A., Khoshbouei, H., Maguire, M., Safe, S., Rhoades, R. E., Clark, R., Jules, G., McCallister, M., et al. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfr261 · Cited by 29
“Interestingly, additional phenotypes of the Cpr-low mouse have already been identified such as female infertility and an altered steroid homeostasis known to occur in human subjects (Artl et al., 2004; Fluck et al., 2004; Fukami et al., 2005, 2006; Huang et al., 2005).”
BackgroundParween, S., Fernández-Cancio, M., Benito-Sanz, S., Camats, N., Rojas Velazquez, M. N., López-Siguero, J.-P., Udhane, S. S., Kagawa, N., Flück, C. E., Audí, L., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa076 · Cited by 28
Self-citationKo, J. M., Cheon, C.-K., Kim, G.-H., & Yoo, H.-W. (2009) · European Journal of Pediatrics · doi:10.1007/s00431-008-0849-0 · Cited by 28
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Self-citationSerafi, I. E., & Steele, S. (2024) · Advances in Pharmacological and Pharmaceutical Sciences · doi:10.1155/2024/4862706 · Cited by 30
Saito, Y., Yamamoto, N., Katori, N., Maekawa, K., Fukushima‐Uesaka, H., Sugimoto, D., Kurose, K., Sai, K., Kaniwa, N., Sawada, J.-I., et al. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-sc-096 · Cited by 27
Sample Prefractionation for Mass Spectrometry Quantification of Low-Abundance Membrane Proteins
Wang, M., Heo, G.-Y., Omarova, S., Pikuleva, I. A., & Turko, I. V. (2012) · Analytical Chemistry · doi:10.1021/ac300587v · Cited by 28
Neunzig, I., Widjaja, M., Peters, F. T., Maurer, H. H., Hehn, A., Bourgaud, F., & Bureik, M. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-013-0303-2 · Cited by 32
Arthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00168-3 · Cited by 29
Velazquez, M. N. R., Parween, S., Udhane, S. S., & Pandey, A. V. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.127 · Cited by 31
Self-citationParween, S., Velazquez, M. N. R., Udhane, S. S., Kagawa, N., & Pandey, A. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01187 · Cited by 24
Self-citationRoles of retinoic acid signaling in normal and abnormal development of the palate and tongue
Okano, J., Udagawa, J., & Shiota, K. (2014) · Congenital Anomalies · doi:10.1111/cga.12049 · Cited by 25
Steroidogenic electron-transfer factors and their diseases
Miller, W. L. (2021) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2142154.077 · Cited by 24
Self-citationSong, T., Wang, B., Chen, H., Zhu, J., & Sun, H. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1393663 · Cited by 24
Prenatal Diagnosis of Antley-Bixler Syndrome and POR Deficiency
Oldani, E., Garel, C., Bucourt, M., & Carbillon, L. (2015) · American Journal of Case Reports · doi:10.12659/ajcr.895526 · Cited by 23
Clinical Use of Progesterone and Its Relation to Oxidative Stress in Ruminants
Kuru, M., Kükürt, A., Oral, H., & ÖĞÜN, M. (2018) · InTech eBooks · doi:10.5772/intechopen.73311 · Cited by 27
Soneda, S., Yazawa, T., Fukami, M., Adachi, M., Mizota, M., Fujieda, K., Miyamoto, K., & Ogata, T. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1337 · Cited by 23
Rare forms of congenital adrenal hyperplasia
Tosun, B. G., & Güran, T. (2023) · Clinical Endocrinology · doi:10.1111/cen.15009 · Cited by 28
Fan, L., Ren, X., Song, Y., Su, C., Fu, J., & Gong, C. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1283-2 · Cited by 22
46,XY disorders of sex development (DSD)
Mendonca, B. B., Domenice, S., Arnhold, I. J. P., & Costa, E. M. F. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02993.x-i1 · Cited by 42
Burris‐Hiday, S. D., & Scott, E. E. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105112 · Cited by 22
Mast, N., Liao, W.-L., Pikuleva, I. A., & Turko, I. V. (2009) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2009.01.002 · Cited by 25
Marohnic, C. C., Huber, W. J., Connick, J. P., Reed, J. R., McCammon, K. M., Panda, S. P., Martasek, P., Backes, W. L., & Masters, B. S. S. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.06.008 · Cited by 27
Functional POR A503V is associated with the risk of bladder cancer in a Chinese population
Xiao, X., Ma, G., Li, S., Wang, M., Liu, N., Ma, L., Zhang, Z., Chu, H., Zhang, Z., & Wang, S. (2015) · Scientific Reports · doi:10.1038/srep11751 · Cited by 23
Haiman, C. A., Setiawan, V. W., Xia, L. Y., Marchand, L. L., Ingles, S. A., Ursin, G., Press, M. F., Bernstein, L., John, E. M., & Henderson, B. E. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4801 · Cited by 22
Aguilar, A., Wu, S., & De Luca, F. (2009) · Endocrinology · doi:10.1210/en.2009-0043 · Cited by 21
Pan, P., Zheng, L., Chen, X., Huang, J., Yang, D., & Li, Y. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00778-0 · Cited by 27
The uncommon forms of congenital adrenal hyperplasia
Auchus, R. J. (2022) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000727 · Cited by 26
Stewart, P. M., & Newell-Price, J. D. C. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-29738-7.00015-0 · Cited by 34
Clinical Implications of Androgen Synthesis via 5&agr;-Reduced Precursors
Ghayee, H. K., & Auchus, R. J. (2008) · KARGER eBooks · doi:10.1159/000134780 · Cited by 23
Tan, T. Y., Jameson, J. L., Campbell, P. E., Ekert, P. G., Zacharin, M., & Savarirayan, R. (2006) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31365 · Cited by 20
Bonamichi, B. D. S. F., Santiago, S. L. M., Bertola, D. R., Kim, C. A., Alonso, N., Mendonca, B. B., Bachega, T. A. S. S., & Gomes, L. G. (2016) · Archives of Endocrinology and Metabolism · doi:10.1590/2359-3997000000213 · Cited by 19
“This variability in enzymatic impairments produces a wide phenotypic spectrum of clinical manifestations ranging from atypical genitalia in both sexes, adrenocortical insufficiency associated or not to bone malformations, to laboratory abnormalities in the neonatal screening test of asymptomatic newborns (1,4-8).”
BackgroundLee, D. H., Lee, H., Yoon, H.-Y., Yee, J., & Gwak, H. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020261 · Cited by 20
Novel SNPs in Cytochrome P450 Oxidoreductase
Hart, S. N., Li, Y., Nakamoto, K., Wesselman, C., & Zhong, X. (2007) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.22.322 · Cited by 20
Zhang, H., Yang, J., Zhang, M., Zhang, W., Liu, J., Wang, W., Ning, G., & Li, X. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03356.x · Cited by 19
Novel CYP17A1 mutation in a Japanese patient with combined 17α-hydroxylase/17,20-lyase deficiency
Katsumata, N., Ogawa, E., Fujiwara, I., & Fujikura, K. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.024 · Cited by 19
Alberola, T. M., Bautista-Llácer, R., Fernández, E., Vendrell, X., & Pérez‐Alonso, M. (2009) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-009-9327-5 · Cited by 18
Non-traditional metabolic pathways of adrenal steroids
Auchus, R. J. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9095-z · Cited by 17
Zhang, T., Li, Z., Ren, X., Huang, B., Zhu, G., Yang, W., & Jin, L. (2020) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-020-01899-z · Cited by 24
Tomková, M., Marohnic, C. C., Gurwitz, D., Šeda, O., Masters, B. S. S., & Martásek, P. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.21 · Cited by 17
Dimopoulou, M., Verhoef, A., van Ravenzwaay, B., Rietjens, I. M. C. M., & Piersma, A. H. (2016) · Reproductive Toxicology · doi:10.1016/j.reprotox.2016.04.003 · Cited by 19
Fang, Y., Gao, N., Tian, X., Zhou, J., Zhang, H., Gao, J., He, X.-P., Wen, Q., Jia, L.-J., Jin, H., et al. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000490934 · Cited by 19
Cytochrome P450 oxidoreductase deficiency with Antley-Bixler syndrome: Steroidogenic capacities
Iijima, S., Ohishi, A., & Ohzeki, T. (2009) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2009.22.5.469 · Cited by 16
Disordered Electron Transfer: New Forms of Defective Steroidogenesis and Mitochondriopathy
Miller, W. L., Pandey, A. V., & Flück, C. E. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae815 · Cited by 17
Self-citationLee, Y., Choi, J.-H., Oh, A., Kim, G.-H., Park, S.-H., Moon, J. E., Ko, C. W., Cheon, C.-K., & Yoo, H.-W. (2020) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.1938152.076 · Cited by 16
Wei, Y., Zhou, X., Fang, C., Li, L., Kluetzman, K., Yang, W., Zhang, Q.-Y., & Ding, X. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167411 · Cited by 17
Arthrogryposes (Multiple Congenital Contractures)
Hall, J. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.05632-4 · Cited by 16
Metadata
- Authors
- Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- Children's Health Ireland at Crumlin (IE)
- Hospital Universitario La Paz (ES)
- Sydney Children's Hospital (AU)
- Johns Hopkins University (US)
- Université de Montréal (CA)
- Tel Aviv University (IL)
- University Children’s Hospital Bern (CH)
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2005-05
- Volume
- 76
- Issue
- 5
- Pages
- 729-749
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1199364
- OpenAlex
- W2062798854
- Semantic Scholar
- 892a16ff5112b5c86510eedcdee62d1812e75a79
- Cited by
- 336
- References
- 99
- Citations by year
- 2026: 9 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 13 · 2021: 9 · 2020: 14 · 2019: 17 · 2018: 15 · 2017: 11 · 2016: 18 · 2015: 16 · 2014: 17 · 2013: 23 · 2012: 14
- FWCI
- 8.28
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 3001 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Funders
- National Institute of General Medical Sciences (R01GM073020, R01GM73020)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK037922, K01DK002939, KO1 DK02939, R01DK37922)
- National Institute of Dental and Craniofacial Research (P60DE013078)
- National Center for Research Resources (M01 RR-00052, M01RR000052)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD41958, R01HD041958)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- cytochrome P450 oxidoreductase, Antley-Bixler syndrome, ambiguous genitalia, FGFR2 mutations, FGFR3 mutation, missense mutations, frameshift mutation, genotype-phenotype correlation, P450c17, 17α-hydroxylase, 17,20-lyase, NADPH oxidation, cytochrome c reduction
- MeSH terms
- Abnormalities, Multiple, Amino Acid Sequence, Craniosynostoses, Female, Genitalia, Humans, Infant, Infant, Newborn, Male, Models, Molecular, Molecular Sequence Data, Mutation, NADPH-Ferrihemoprotein Reductase, Steroids, Syndrome, Genetic Variation, Sequence Alignment, Receptors, Fibroblast Growth Factor, Receptor Protein-Tyrosine Kinases, Receptor, Fibroblast Growth Factor, Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.